THYQUIDITY Drug Patent Profile
✉ Email this page to a colleague
When do Thyquidity patents expire, and what generic alternatives are available?
Thyquidity is a drug marketed by Vistapharm and is included in one NDA. There is one patent protecting this drug.
This drug has eleven patent family members in eleven countries.
The generic ingredient in THYQUIDITY is levothyroxine sodium. There are ten drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Thyquidity
A generic version of THYQUIDITY was approved as levothyroxine sodium by MYLAN on June 5th, 2002.
Summary for THYQUIDITY
| International Patents: | 11 |
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for THYQUIDITY |
| What excipients (inactive ingredients) are in THYQUIDITY? | THYQUIDITY excipients list |
| DailyMed Link: | THYQUIDITY at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for THYQUIDITY
US Patents and Regulatory Information for THYQUIDITY
THYQUIDITY is protected by one US patents.
Patents protecting THYQUIDITY
Method for the preparation of a levothyroxine solution
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vistapharm | THYQUIDITY | levothyroxine sodium | SOLUTION;ORAL | 214047-001 | Nov 30, 2020 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for THYQUIDITY
See the table below for patents covering THYQUIDITY around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Poland | 2683361 | See Plans and Pricing | |
| Croatia | P20151421 | See Plans and Pricing | |
| Slovenia | 2683361 | See Plans and Pricing | |
| Hungary | E028423 | See Plans and Pricing | |
| Serbia | 54524 | POSTUPAK PRIPREME RASTVORA LEVOTIROKSINA (METHOD FOR THE PREPARATON OF A LEVOTHYROXINE SOLUTION) | See Plans and Pricing |
| Denmark | 2683361 | See Plans and Pricing | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2022 - 2023
NCE-1 Patent Challenge Dates 2022 - 2023
ClinicalTrialExchange - Connecting volunteers and trials
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2022, www.DrugPatentWatch.com.
Follow DrugPatentWatch:
